Procedures in patients with coagulopathies: Difference between revisions

No edit summary
No edit summary
Line 2: Line 2:
*All of the below rules are guidelines with mostly retrospective and case report evidence.  All rules need to account for operator experience. The most experienced operator should perform the procedure.
*All of the below rules are guidelines with mostly retrospective and case report evidence.  All rules need to account for operator experience. The most experienced operator should perform the procedure.


==[[Central Line]]==
==[[Central line|Central Line]]==
*If coagulopathic, use a compressible site such as the femoral location (avoid the IJ and Subclavian if possible)
{{Central line with coagulopathy}}
*No benefit FFP unless you lacerate an artery<ref>Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy—a prospective audit. Intens Care Med 1999; 25:5</ref>
**However, consider if patient has [[Hemophilia|hemophilia]]<ref>Morado M.et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001; 7:551–556</ref>


==[[Lumbar Puncture]]==
==[[Lumbar Puncture]]==

Revision as of 19:43, 11 January 2015

Background

  • All of the below rules are guidelines with mostly retrospective and case report evidence. All rules need to account for operator experience. The most experienced operator should perform the procedure.

Central Line

Central line if coagulopathic

  • Preferentially use a compressible site such as the femoral location (avoid the IJ and subclavian if possible, though IJ preferred over subclavian)
  • No benefit to giving FFP unless artery is punctured[1]

Lumbar Puncture

Lumbar puncture if coagulopathic

  • Tranfuse if platelets <25,000[3][4]
  • INR >1.5
  • Hemophilia, von Willebrand disease, other coagulopathies
    • If hemophiliac, replace factor before LP

Paracentesis

  • Coagulation studies are NOT required before performance of the procedure[5]
  • No data supports cutoff values beyond which paracent should be avoided/prophylactically transfused
  • Routine use of FFP and platelets is not recommended
  • Contraindicated if the patient is actively bleeding or in DIC and the incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)[6]

Thoracentesis

  • Consider transfusion of platelets if platelets <50,000, or Fresh Frozen Plasma if PT/PTT twice the normal range [7]



See Also

Further Reading

  • Indravadan P. et al. Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Image-guided Interventions. J Vasc Interv Radiol 2012 PDF

Sources

  • Roberts, Clin Proc Emer Med 2004; Yu (Clin Liv Dz '01)
  1. ↑ Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy—a prospective audit. Intens Care Med 1999; 25:5
  2. ↑ Morado M.et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001; 7:551–556
  3. ↑ Howard SC, Gajjar A, Ribeiro RC, et al. Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA 2000; 284:2222–2224
  4. ↑ Vavricka SR, Walter RB, Irani S, Halter J, Schanz U. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion. Ann Hematol 2003; 82:570–573
  5. ↑ Wilkerson, Annals of Emerg Med, 2009
  6. ↑ Thomsen TW. Paracentesis. N Engl J Med 2006; 355: e21
  7. ↑ McVay P. et al. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991 Feb;31(2):164-71
Retrieved from "https://www.wikem.org/w/index.php?title=Procedures_in_patients_with_coagulopathies&oldid=28987"